[{"command":"openDialog","selector":"#drupal-modal","settings":null,"data":"\u003Cdiv id=\u0022republish_modal_form\u0022\u003E\u003Cform class=\u0022modal-form-example-modal-form ecl-form\u0022 data-drupal-selector=\u0022modal-form-example-modal-form\u0022 action=\u0022\/en\/article\/modal\/7235\u0022 method=\u0022post\u0022 id=\u0022modal-form-example-modal-form\u0022 accept-charset=\u0022UTF-8\u0022\u003E\u003Cp\u003EHorizon articles can be republished for free under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.\u003C\/p\u003E\n \u003Cp\u003EYou must give appropriate credit. We ask you to do this by:\u003Cbr \/\u003E\n 1) Using the original journalist\u0027s byline\u003Cbr \/\u003E\n 2) Linking back to our original story\u003Cbr \/\u003E\n 3) Using the following text in the footer: This article was originally published in \u003Ca href=\u0027#\u0027\u003EHorizon, the EU Research and Innovation magazine\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003ESee our full republication guidelines \u003Ca href=\u0027\/horizon-magazine\/republish-our-stories\u0027\u003Ehere\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003EHTML for this article, including the attribution and page view counter, is below:\u003C\/p\u003E\u003Cdiv class=\u0022js-form-item form-item js-form-type-textarea form-item-body-content js-form-item-body-content ecl-form-group ecl-form-group--text-area form-no-label ecl-u-mv-m\u0022\u003E\n \n\u003Cdiv\u003E\n \u003Ctextarea data-drupal-selector=\u0022edit-body-content\u0022 aria-describedby=\u0022edit-body-content--description\u0022 id=\u0022edit-body-content\u0022 name=\u0022body_content\u0022 rows=\u00225\u0022 cols=\u002260\u0022 class=\u0022form-textarea ecl-text-area\u0022\u003E\u003Ch2\u003E\u2018I don\u2019t see any other way out\u2019: Diagnostic testing and smartphone contact tracing to beat pandemic\u003C\/h2\u003E\u003Cp\u003EThe discovery of one virus, two colonies was made by Professor Christian Drosten, the virologist who collaborated on the first \u003Ca href=\u0022https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2020.25.3.2000045\u0022 target=\u0022_blank\u0022 rel=\u0022noopener noreferrer\u0022\u003Ediagnostic test\u003C\/a\u003E for the SARS-CoV-2 virus outside of China. Prof. Drosten describes his discovery, which was presented in \u003Ca href=\u0022https:\/\/www.nature.com\/articles\/s41586-020-2196-x\u0022 target=\u0022_blank\u0022 rel=\u0022noopener noreferrer\u0022\u003E\u003Cem\u003ENature\u003C\/em\u003E\u003C\/a\u003E earlier this month, as a \u2018game changer\u2019 and explains the virus\u2019s unbridled spread.\u003C\/p\u003E\u003Cp\u003EIn late January of this year, when coronavirus transmission within Europe was assumed to be minimal, Prof. Drosten\u2019s team took swab samples from the lungs and throats of a small group of Munich residents experiencing mild Covid-19 symptoms. They found high levels of viral replication in the throats of nine.\u003C\/p\u003E\u003Cp\u003E\u2018What was surprising is that we saw different, discriminable virus populations in the two locations, which really proves different compartments of the virus,\u2019 said Prof. Drosten, who is based at Berlin\u2019s Charit\u00e9 Institute of Hygiene and Environmental Medicine. \u2018Both virus populations were replicating autonomously. This is a discriminating feature, a whole different type of behaviour, not seen in viruses like Sars (\u003Cem\u003Esevere acute respiratory syndrome).\u2019\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003EHe continued: \u2018Sars goes straight to the lung and starts replicating there. The lung is full of immune tissue, and it is the kicking in of your immunity that makes you feel sick. So with SARS, even before the virus accumulates to a concentration that makes it infectious, you feel unwell. With such a virus, the isolation of cases based on symptoms is easy \u2013 first you get the symptoms, then the infectivity.\u2019\u003C\/p\u003E\u003Cp\u003EThe pathogen responsible for the Covid-19 pandemic is often compared to the 2002\u20133 Sars virus \u2013 both are novel coronaviruses and both trigger acute respiratory symptoms \u2013 however, Sars was responsible for \u003Ca href=\u0022https:\/\/www.nhs.uk\/conditions\/sars\/\u0022 target=\u0022_blank\u0022 rel=\u0022noopener noreferrer\u0022\u003E774 deaths\u003C\/a\u003E, while Covid-19 fatalities stand at 130,000 and are rising.\u003C\/p\u003E\u003Cp\u003EProf. Drosten believes the throat-borne nature of the SARS-CoV-2 virus explains the alarming level of transmission. His study drew on the case of one afflicted individual who infected 14 other people from virus particles emanating from her throat, setting off a chain of coronavirus infections that led to a Munich outbreak.\u003C\/p\u003E\u003Cp\u003E\u2018With a throat-borne pathogen, the virus arrives and replicates in the throat, and all you feel is an itch or a soreness or even nothing. As it replicates to an infectious concentration, there\u2019s still no reaction from your immune system,\u2019 he said.\u003C\/p\u003E\u003Cp\u003E\u2018Only a few days later, when the virus spreads from the throat to the lung, do symptoms kick in. At that point, you\u2019ve already been spreading the virus for a few days. As we know now, about 45% of all infectious events (with the coronavirus) occur before the onset of symptoms.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cblockquote class=\u0022tw-text-center tw-text-blue tw-font-bold tw-text-2xl lg:tw-w-1\/2 tw-border-2 tw-border-blue tw-p-12 tw-my-8 lg:tw-m-12 lg:tw--ml-16 tw-float-left\u0022\u003E\n \u003Cspan class=\u0022tw-text-5xl tw-rotate-180\u0022\u003E\u201c\u003C\/span\u003E\n \u003Cp class=\u0022tw-font-serif tw-italic\u0022\u003E\u2018There\u2019s so much virus produced in the throat, I\u2019m optimistic a self-deployed throat swab will be able to detect virus proteins early on in an infection.\u2019\u003C\/p\u003E\n \u003Cfooter\u003E\n \u003Ccite class=\u0022tw-not-italic tw-font-normal tw-text-sm tw-text-black\u0022\u003EProfessor Christian Drosten, Charit\u00e9 Institute of Hygiene and Environmental Medicine, Berlin, Germany \u003C\/cite\u003E\n \u003C\/footer\u003E\n\u003C\/blockquote\u003E\n\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAggressive testing\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003ELike the vast majority of scientists on the coalface of the Covid-19 response, Prof. Drosten regards aggressive testing within populations as essential if the world is to get on top of the pandemic. He believes new diagnostic approaches, aimed at identifying an infection in its earliest phases, will help close the gap between diagnosis of an infection and transmission of the virus.\u003C\/p\u003E\u003Cp\u003E\u2018Even if you identify patients on the day of symptom onset and immediately lock them in, you\u2019ve already lost half of the time that you\u2019d like to have to prevent all infections,\u2019 he said.\u003C\/p\u003E\u003Cp\u003ETests currently on the market have limited power in slowing transmission. The polymerase chain reaction (PCR) test is the standard coronavirus test, and the one Prof. Drosten\u2019s lab has been producing since January and distributing around the world as a partner of the \u003Ca href=\u0022https:\/\/cordis.europa.eu\/project\/id\/871029\u0022 target=\u0022_blank\u0022 rel=\u0022noopener noreferrer\u0022\u003EEuropean Virus Archive \u2013 Global\u003C\/a\u003E project.\u003C\/p\u003E\u003Cp\u003EThe PCR test detects signs of the virus\u2019s genetic material, but by the time most people receive their results, the infection is well established and the virus has spread. A swab needs to pick up a certain quantity of virus to give a true result, which means the PCR test works best on well established infections. Though the test is very sensitive, it is possible for it to miss the virus and yield a false negative result.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.17.20037713v1.full.pdf\u0022\u003EThe eagerly anticipated serological test\u003C\/a\u003E\u0026nbsp;\u2013 which will show when a person has developed antibodies against the virus, thereby indicating that an infection has already passed \u2013 will do nothing to stem the flow of virus particles from one individual to another.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EPromise is being shown, however, by antigen tests intended for home use, says Prof. Drosten. These tests will diagnose an infection even before symptoms appear, so a person could be tested soon after coming into contact with an infected individual.\u003C\/p\u003E\u003Cp\u003E\u2018There\u2019s so much virus produced in the throat, I\u2019m optimistic a self-deployed throat swab will be able to detect virus proteins early on in an infection,\u2019 said Prof. Drosten. \u2018In the beginning, these tests will be expensive, but ultimately the cost to produce them will be the same as the cost to produce a pregnancy test.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAntigen tests\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EAntigen tests are far harder to develop than antibody tests as they require the inclusion of artificial antibodies and producing these is not straightforward. But biotech companies have been working hard to crack the formulation and Prof. Drosten says antigen test kits are \u2018available now\u2019. The first prototypes will be trialled in labs, including his, within the next few weeks.\u003C\/p\u003E\u003Cp\u003E\u2018Two to three months would be my best estimate for the first tests to appear on the market,\u2019 he said.\u003C\/p\u003E\u003Cp\u003EHerman Goossens, professor of medical microbiology at the University of Antwerp in Belgium, welcomes the research focus on home-based diagnostic kits. However, he says more thought needs to be given to the usefulness of test results.\u003C\/p\u003E\u003Cp\u003E\u2018How will it help you to have antigen and antibody tests on the market? Can you use them (an antibody test) to send guarantees that you can\u2019t infect other people? Can you use them (an antigen test) to rapidly start antiviral treatment? There are many things to think about,\u2019 he said.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAntivirals\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWhile health authorities grapple with the options, Prof. Goossens, who is project coordinator of the \u003Ca href=\u0022https:\/\/cordis.europa.eu\/project\/id\/602525\u0022 target=\u0022_blank\u0022 rel=\u0022noopener noreferrer\u0022\u003EPREPARE\u003C\/a\u003E project set up in 2014 as a platform for European preparedness against emerging epidemics, is eager for testing to be ramped up on antiviral treatments. The aim of these drugs will be to stop the virus from replicating once an infection has become established.\u003C\/p\u003E\u003Cp\u003EEffective antivirals coupled with home-based tests have the potential to greatly reduce hospital admissions, says Prof. Goossens. \u2018If, for example, an elderly person develops symptoms, you could give them a home-based test, and if they are positive for the virus, they could immediately start taking an antiviral drug, and this would hopefully reduce the number of elderly people admitted to hospital.\u2019\u003C\/p\u003E\u003Cp\u003ELaboratories across Europe linked to the PREPARE project are currently running trials on antiviral treatments originally intended as remedies for a range of conditions, including Ebola, HIV and malaria.\u003C\/p\u003E\u003Cp\u003E\u2018Developing a new drug takes five to 10 years, which is why we are looking at existing drugs. In a month or so, we should have some preliminary results showing if the drugs we are testing work or not,\u2019 said Prof. Goossens.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EContact tracing\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EIn Prof. Drosten\u2019s view, Europe will need to look beyond diagnostics and existing treatments to bring the coronavirus to heel in the absence of a vaccine. He believes our greatest hope is to pair diagnostic testing with \u003Ca href=\u0022https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/IP_20_626\u0022\u003Econtact tracing using smartphone technology\u003C\/a\u003E.\u003C\/p\u003E\u003Cp\u003ETo this end, leading tech companies are working on apps designed to automate contact tracing - a process that is currently putting a huge burden on public health professionals. This software will give communities a safe way out of lockdown, says Prof. Drosten, though at least 70% of Europeans would need to adopt the same app for the intervention to be effective.\u003C\/p\u003E\u003Cp\u003EHe explains how the technology would work. \u2018You enter a symptom in a checkbox on your phone and the app will order a diagnostic test for you and identify the people you\u2019ve had contacts with in the last five days. Then you and all your contacts lock yourselves away immediately, while everyone else who is not tarred by your transmission chain has the freedom to travel and work.\u2019\u003C\/p\u003E\u003Cp\u003EHe said an app-based public health intervention of this kind would give Europe a chance to \u2018revive\u2019 after the first wave of the pandemic. Without it, the virus will resurge time and again, resulting in repeated episodes of population-wide quarantining.\u003C\/p\u003E\u003Cp\u003E\u2018An app approach would be much more detailed and specific than the total lockdown we are having now, and it is what we need,\u2019 he said. \u2018I don\u2019t see any other way out.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003EThe research in this article was funded by the EU. If you liked this article, please consider sharing it on social media.\u003C\/em\u003E\u003C\/p\u003E\u003C\/textarea\u003E\n\u003C\/div\u003E\n\n \u003Cdiv id=\u0022edit-body-content--description\u0022 class=\u0022ecl-help-block description\u0022\u003E\n Please copy the above code and embed it onto your website to republish.\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003Cinput autocomplete=\u0022off\u0022 data-drupal-selector=\u0022form-2iwkunu4r5dj-xbdy31abzt4cxbp0cpglacajljitv4\u0022 type=\u0022hidden\u0022 name=\u0022form_build_id\u0022 value=\u0022form-2iwKUNu4r5dJ_xbDY31abzT4cxBP0CpGLACAJlJiTV4\u0022 \/\u003E\n\u003Cinput data-drupal-selector=\u0022edit-modal-form-example-modal-form\u0022 type=\u0022hidden\u0022 name=\u0022form_id\u0022 value=\u0022modal_form_example_modal_form\u0022 \/\u003E\n\u003C\/form\u003E\n\u003C\/div\u003E","dialogOptions":{"width":"800","modal":true,"title":"Republish this content"}}]